186 related articles for article (PubMed ID: 28958730)
1. Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients.
Zhang H; Zhang W; Li Y; Yan J; Zhang J; Wang B
Brain Dev; 2018 Feb; 40(2):100-106. PubMed ID: 28958730
[TBL] [Abstract][Full Text] [Related]
2. Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.
Saleh Faisal M; Jamil A; Ali N; Alshahrani AM; Almarshad F
Gene; 2024 Jan; 892():147886. PubMed ID: 37820941
[TBL] [Abstract][Full Text] [Related]
3. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients.
Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K
Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988
[TBL] [Abstract][Full Text] [Related]
4. Effect of UGT2B7 genetic variants on serum valproic acid concentration.
Ma H; Zhang T; Gong Z; Zhou B; Zou M; Xiao S; Zhu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):766-72. PubMed ID: 23981985
[TBL] [Abstract][Full Text] [Related]
5. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
[TBL] [Abstract][Full Text] [Related]
6. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.
Chu XM; Zhang LF; Wang GJ; Zhang SN; Zhou JH; Hao HP
Eur J Clin Pharmacol; 2012 Oct; 68(10):1395-401. PubMed ID: 22476391
[TBL] [Abstract][Full Text] [Related]
7. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients].
Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M
Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473
[TBL] [Abstract][Full Text] [Related]
8. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
9. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
[TBL] [Abstract][Full Text] [Related]
10. Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy.
Zhao M; Chen Y; Wang M; Li G; Zhao L
Ther Drug Monit; 2020 Oct; 42(5):760-765. PubMed ID: 32107351
[TBL] [Abstract][Full Text] [Related]
11. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.
Guo Y; Hu C; He X; Qiu F; Zhao L
Drug Metab Pharmacokinet; 2012; 27(5):536-42. PubMed ID: 23099353
[TBL] [Abstract][Full Text] [Related]
12. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
13. Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients.
Lu Q; Huang YT; Shu Y; Xu P; Xiang DX; Qu Q; Qu J
Medicine (Baltimore); 2018 Jul; 97(30):e11662. PubMed ID: 30045320
[TBL] [Abstract][Full Text] [Related]
14. Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy.
Wang Y; Li Z
Therapie; 2020; 75(3):261-270. PubMed ID: 31474408
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
[TBL] [Abstract][Full Text] [Related]
16. The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients.
Sun YX; Zhuo WY; Lin H; Peng ZK; Wang HM; Huang HW; Luo YH; Tang FQ
Epilepsy Res; 2015 Aug; 114():78-80. PubMed ID: 26088889
[TBL] [Abstract][Full Text] [Related]
17. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
Minkova GD; Getova DP
Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
[TBL] [Abstract][Full Text] [Related]
18. Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children.
Du Z; Jiao Y; Shi L
Med Sci Monit; 2016 Oct; 22():4107-4113. PubMed ID: 27795544
[TBL] [Abstract][Full Text] [Related]
19. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].
Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR
Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769
[TBL] [Abstract][Full Text] [Related]
20. Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model.
Mei S; Feng W; Zhu L; Li X; Yu Y; Yang W; Gao B; Wu X; Fang F; Zhao Z
Eur J Clin Pharmacol; 2018 Aug; 74(8):1029-1036. PubMed ID: 29666902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
